Skip to main content
. 2021 Mar 12;12:623681. doi: 10.3389/fpsyt.2021.623681

Figure 3.

Figure 3

(A,B) Clinical guideline and decision support for the assessment, prevention, and treatment of metabolic adverse effects of antipsychotic medications in youth. Adapted from the American Academy of Child and Adolescent Psychiatry (7) and American Psychiatric Association and American Diabetes Association Guidelines (70). (A) Initial Assessment and Plan. (B) Follow-up Assessment and Plan.